Skip to content
Highlights
– The new Actavis plc is a powerful combination of the highly successful and previously separate Actavis, Inc. (NYSE:ACT) and Warner Chilcott plc (NASDAQ: WCRX)
– Operating as Actavis Pharma, our generic, branded generic, legacy brands and Over-the-Counter (OTC) business markets more than 750 products globally through operations in more than 60 countries.
– Actavis Specialty Brands is a global branded specialty pharmaceutical business focused principally in the Women’s Health, Urology, Gastroenterology and Dermatology therapeutic categories.
– Actavis is committed to developing and marketing biosimilar products in Women’s Health, Oncology and other therapeutic categories.
– Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, and includes Anda, Inc., a U.S. pharmaceutical product distributor.
– Actavis develops and out-licenses generic pharmaceutical products to customers in more than 100 countries outside of the U.S. through its Medis third-party business.
×

EAHP BOOST 25

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.

REGISTER HERE!